JBM is a Hong Kong-based branded healthcare company with product footprint covering Greater China, Southeast Asia and certain other countries.
Tag: Jacobson Pharma
Jacobson Pharma Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of BioNTech SEs COVID-19 Vaccine Candidate in Hong Kong and Macau
In the collaboration, Jacobson Pharma will provide all relevant support services to Fosun Pharma Group for the marketing, sales and distribution of the COVID-19 Vaccine in Hong Kong and Macau SAR regions through its extensive sales and distribution network amongst the hospital and medical clinic sectors in the region.
Jacobson Pharma Announces FY2020 Annual Results
Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines
Jacobson Pharma Launches First Influenza RSV Home Diagnostic Kit in Hong Kong and Macau
Jacobson launches Dr. Freeman Flu/RSV Combo as its first influenza/RSV home diagnostic kit in the markets of Hong Kong and Macau. It is designed for qualitative determination of specific types of Influenza A and B virus and respiratory syncytial virus (“RSV”) with test results available in 8 minutes.
Jacobson Pharma Forms Joint Venture with Kin Fung Weisen-U
Expands Branded Product Portfolio and Develops New Markets for Gastrointestinal and Respiratory Products